Shenzhen Hepalink Pharmaceutical Co Ltd (002399) — Cash Flow Reinvestment Rate
Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Cash Flow Reinvestment Rate of 0.03x as of September 2025, reinvesting CN¥13.60 Million (capex CN¥13.60 Million ) from operating cash flow of CN¥399.43 Million. Check cash flow quality index of Shenzhen Hepalink Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Shenzhen Hepalink Pharmaceutical Co Ltd across 16 annual periods. Explore Shenzhen Hepalink Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)
Year-by-year capital reinvestment analysis for Shenzhen Hepalink Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Shenzhen Hepalink Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | CN¥763.43 Million | CN¥1.71 Billion | CN¥121.10 Million | ▲ +287.0% |
| 2024 | 0.12x | CN¥252.68 Million | CN¥2.19 Billion | CN¥202.77 Million | ▼ -97.2% |
| 2023 | 4.18x | CN¥1.67 Billion | CN¥398.22 Million | CN¥444.88 Million | ▼ -93.1% |
| 2020 | 60.36x | CN¥2.25 Billion | CN¥37.28 Million | CN¥212.49 Million | ▲ +1329.2% |
| 2018 | 4.22x | CN¥2.82 Billion | CN¥667.87 Million | CN¥535.01 Million | ▲ +131.1% |
| 2016 | 1.83x | CN¥632.55 Million | CN¥346.07 Million | CN¥359.54 Million | ▲ +867.4% |
| 2015 | 0.19x | CN¥168.85 Million | CN¥893.71 Million | CN¥168.85 Million | ▲ +2.9% |
| 2014 | 0.18x | CN¥167.62 Million | CN¥912.80 Million | CN¥167.62 Million | ▼ -73.7% |
| 2013 | 0.70x | CN¥293.98 Million | CN¥420.97 Million | CN¥293.98 Million | ▲ +39.3% |
| 2012 | 0.50x | CN¥237.55 Million | CN¥473.89 Million | CN¥237.55 Million | ▲ +425.0% |
| 2011 | 0.10x | CN¥134.16 Million | CN¥1.41 Billion | CN¥134.16 Million | ▼ -5.7% |
| 2010 | 0.10x | CN¥35.93 Million | CN¥354.86 Million | CN¥35.93 Million | ▼ -34.4% |
| 2009 | 0.15x | CN¥54.91 Million | CN¥355.81 Million | CN¥54.91 Million | ▼ -42.7% |
| 2008 | 0.27x | CN¥10.81 Million | CN¥40.13 Million | CN¥10.81 Million | ▼ -68.8% |
| 2007 | 0.86x | CN¥11.95 Million | CN¥13.85 Million | CN¥11.95 Million | ▲ +477.7% |
| 2006 | 0.15x | CN¥10.71 Million | CN¥71.66 Million | CN¥10.71 Million | — |